Aphea.Bio
Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.
Aphea.Bio has raised €84M across 2 funding rounds from 6 investors, most recently a Series C round in Jul 2023. Based in Zwijnaarde, Belgium; founded 2017; active in Agritech. Data as of 28 Oct 2026.
Total raised
€84M
€84,000,000
Funding rounds
2
Investors
6
distinct backers
Active since
2020-11
latest 2023-07
Funding by year
EUR raised per yearAphea.Bio — funding by year — interactive chart.
Data table
| Aphea.Bio — funding by year | |
|---|---|
| 2020 | €14M |
| 2023 | €70M |
Signals
High confidenceRaise-next likelihood10
base rate 50% for Series C
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-07-12 | Series C | €70M | Astanor Ventures,Bill & Melinda Gates Foundation Trust,BNP Paribas Fortis,European Circular Bioeconomy Fund (ECBF),Innovation Industries,Korys | View deal → |
| 2020-11-30 | Series B | €14M | Astanor Ventures | View deal → |